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Background: Multiple studies have occurred to determine if a patient’s blood type, Rhesus factor (Rh), and
sociodemographic attributes contribute to contracting SARS-CoV-2. True association remains unknown.
Methods: Inclusion criteria included in-patients who were tested for SARS-CoV-2 with blood type assessed.
Study endpoints combined ABO, Rh and all-cause inpatient mortality (ACIM) with testing positivity. Pregnancy
status was one of several secondary endpoints evaluated. A logistic regression analysis was used to estimate
association.
Results: Of the 27,662 patients who met inclusion criteria, Type A blood was associated with increased positivity [1.01 (1.0-1.21), P = .03]. Type B [1.10 (0.99-1.23), P = .08] and AB [0.98 (0.81-1.19), P = .84] showed no
association. When evaluating ACIM, type A [1.18 (0.91-1.52), P = .22], B [1.13 (0.82- 1.56), P = .480], and AB
[1.06 (0.62-1.81), P = .839] were not associated with increased mortality. The female subgroup was less likely
to test positive [0.88 (0.82-0.986), P = .002]. Black patients demonstrated a higher likelihood of positivity
when compared to White [1.96 (1.79-2.14), P < .001]. Non-pregnant women exhibited a 2.5 times greater
likelihood of testing positive [2.49 (2.04-3.04), P < .001].
Conclusions: This study conﬁrms results of previous research which showed SARS-Co-V-2 positivity related
to blood type. It also conﬁrms more recent research demonstrating inequities related to acquisition of SARSCoV-2 for certain sociodemographic groups. Larger studies are warranted to conﬁrm and further explore
novel pregnancy ﬁndings.
© 2022 The Author(s). Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control
and Epidemiology, Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/)
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multiple tests for SARS-CoV-2, the ﬁrst test with a positive result
was used and all others excluded. Primary study end points combined ABO blood type and Rh with likelihood of testing positive and
all-cause inpatient mortality (ACIM). Secondary end points included
age, gender, race, and body mass index (BMI). There was a subgroup
analysis focused on women of childbearing age and pregnancy status.

The role sociodemographic and genetic factors play in susceptibility
to SARS-CoV-2 transmission and disease progression still remains
unclear. Initial studies from Italy, Spain, China and Denmark have
implied that, in contrast to blood type O, those individuals with blood
type A were associated with an increased vulnerability to SARS-CoV2.1-3 However, more recent research conducted in the United States
did not show a correlation between blood type and SARS-CoV-2.4-7
While there is limited data supporting how genetics and sociodemographic variables contribute to susceptibility, one current study
found race to be a contributing factor.7 The purpose of this case-control study was to explore if blood type and socio-demographic factors
contribute to SARS-CoV-2 susceptibility and mortality. It is notably
one of the ﬁrst investigations to examine the relationship between
pregnancy status and disease acquisition.

Statistical analysis
Association amongst patient characteristics with blood type,
SARS-CoV-2 test positivity, and mortality were analyzed using Chi
squared and Fisher’s exact test for discrete variables while the
continuous variables were analyzed with ANOVA and unpaired ttest. Logistic regression analysis was used to estimate the association of blood type with testing positive for SARS-CoV-2 and mortality, adjusting for baseline characteristics that were associated
with blood type including age, race, and gender. A subgroup analysis was conducted on women of childbearing age (13-49). These
analyses were performed using SAS v9.4 (SAS Institute, Cary, NC).
All p-values are two-sided and p-values less than 0.05 were considered signiﬁcant. Odds ratios (OR) were utilized and conﬁdence
intervals (CI) were set at 95%.

METHODS
This IRB approved, case-controlled study was conducted at the
Jefferson University Hospitals located in New Jersey and Pennsylvania from March 2020 through March 2021. Inclusion criteria
included all admitted adult patients, ages 18 years and older, who
were tested for SARS-CoV-2. Patients were excluded if they did not
have a recorded blood type upon admission. For patients who had

Table 1
Individual characteristics for SARS-CoV-2 positivity
Blood Type

A

AB

B

O

Total

Total N,%
Age (mean, SD)
Gender
Male
Female
*BMI mean, (SD)
Not Obese
Obese*
Race
White
Black
Other

9227 (33.4%)
57.3 (19.0)

1260 (4.6%)
57.3 (19.3)

4218 (15.2%)
55.5 (19.2)

12957 (46.8%)
56.1 (19.3)

27,662
56.3 (19.2)

43%
57%
29.5 (8.8)
61.6%
38.4%

45%
55%
27.6 (8.9)
75%
25%

41%
59%
29.5 (7.9)
57.6%
42.4%

41%
59%
29.1 (7.6)
61.8%
38.2%

42%
58%
29.3 (8.1)
61%
39%

70%
20.6%
9.3%

59.4%
30.7%
9.8%

47.1%
38.9%
14%

57.2%
31%
11.8%

60%
28.7%
11.3%

P value
<0.001
0.002

0.798

<0.001

*Obese deﬁned as Body Mass Index (BMI) ≥ 30 kg/m2

Fig 1. Odds of testing positive for SARS CoV2 by blood type*.
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Fig 2. Odds of testing positive by blood type and Rh.

RESULTS
A total of 27,662 patients who had been tested for SARS-CoV-2
infection were included in the study. Of these patients, 42% were
male, mean age was 56.3 [19.2] years [SD] and 60% were of white
race. Average BMI was 29.3 [8.1] kg/m2 [SD] and 39% of patients were
considered obese. Further demographic characteristics of the studied
population and ABO blood group associations are seen in Table 1.
Overall, blood type O (-) was found to have the lowest number of positive tests. ACIM was the highest in blood group A (-) and lowest in O
(+). Blood type A was associated with an increased odds of positivity
[1.01 (1.0-1.21), P = .03] as seen in Figure 1. However, blood types B
and AB did not show an association. Analysis of blood type in combination with Rh revealed no association with increased positivity
when compared with blood type O (+) (Fig 2). Additionally, females

Table 2
Demographics for women of childbearing age

Race
White, N (%)
Black, N (%)
Other, N (%)
Age, (SD)
Age (categorical)
<35, N (%)
≥35, N (%)
Pregnancy Status
No, N (%)
Yes, N (%)
Blood Type
A, N (%)
AB, N (%)
B, N (%)
O, N (%)

Total
(N = 6904)

COVID
Negative
(N = 6234)

COVID
Positive
(N = 670)

2500 (36.2)
3165 (45.8)
1239 (18.0)
33.4 (7.9)

2185 (35.1)
2943 (47.2)
1106 (17.7)
33.4 (7.9)

315 (47.0)
222 (33.1)
133 (19.9)
33.7 (8.1)

3985 (57.7)
2919 (42.3)

3610 (57.9)
2624 (42.1)

375 (56.0)
295 (42.3)

4256 (61.7)
2648 (38.4)

3744 (60.1)
2490 (39.9)

512 (76.4)
158 (23.6)

2188 (31.7)
293 (4.2)
1127 (16.3)
3296 (47.7)

1982 (31.8)
267 (4.3)
1016 (16.3)
2969 (47.6)

206 (30.8)
26 (3.9)
111 (16.6)
327 (48.8)

P value

<0.001

0.416
0.335

<0.001

0.886

were less likely to test positive than males [(0.88 (0.82-0.98),
P = .002)], and black patients were more likely to test positive than
white patients [(1.96 (1.79-2.14), P < .001)].
Analysis of results women of childbearing age
In the subgroup of women of childbearing age, the associations of
age, race, blood type, and pregnancy status with COVID positivity
was examined (Table 2). Race and pregnancy status were associated
with COVID positivity (P < .001 in both cases). Race showed an association with pregnancy status in women who were COVID + (P < .001)
and COVID − (P < .001). Likewise, COVID positivity was associated
with race in both non pregnant (P < .001) and pregnant (P < .001)
patients. Pregnancy status was associated with categorical age in
women who were both COVID + (P < .001) and COVID - (P < .001).
For women who were not pregnant, COVID positivity was associated
with age (P = .023). In a multivariable analysis adjusted for age and
race (Fig 3), none of the blood types were associated with increased
positivity when compared with blood type O. As in the overall study
population, black race was associated with increased testing positivity when compared with white race [(2.07 (1.72-2.50), P < .001)] in
this cohort as well. Moreover, pregnant patients were less likely to
test positive for SARS-CoV-2 than non-pregnant patients (OR nonpregnant vs. pregnant=2.49 (2.05-3.05), P < .001).
Limitations
One identiﬁed study limitation is that BMI data was not consistently available for all patients in the study. Therefore, we could not
control for BMI in the logistic regression model. Also, this is a casecontrol study in which the cases and controls were recruited from an
in-patient setting. This has the potential to produce selection bias as
hospital patients may have characteristics different than the general,
non-hospitalized community. Immunization status was not a factor
in this study as vaccinations were not available to the general public,
including our study population, until April of 2021.Therefore,
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Fig 3. Odds of testing positive for SARS-CoV-2 in women of childbearing age.

immunization status is not relevant, nor considered a limitation for
this study.

positivity is affected by physiological, social, or behavioral factors, or
inﬂuenced by a combination of causes.

DISCUSSION
This case-controlled study, consisting of 27,662 patients, supported initial international studies which demonstrated a signiﬁcant
correlation between blood type A and SARS-CoV-2 susceptibility.1-3
When evaluating subgroups, additional ﬁndings demonstrated evidence that females were less likely to test positive for SARS-CoV-2
than men for all age groups. Black patients were more susceptible to
SARS-CoV-2 than Whites.7 The most novel ﬁnding of this study is the
association of SARS-CoV-2 positivity in women of childbearing age.
This research suggests that non-pregnant women were 2.5 times
more likely to test positive for SARS-Co-V-2 than pregnant women.
This study is the ﬁrst to identify a correlation between pregnancy status and SARS-CoV-2 positivity and can add to the limited body of
knowledge that exists pertaining to this population and SARS-CoV-2.
More research is warranted to support this ﬁnding and to explore if
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